White Spot Syndrome and Disease Welfare in Farmed Shrimp

Infectious disease is one of the most significant welfare and economic problems in global shrimp aquaculture. White Spot Syndrome Virus (WSSV) and other pathogens cause mass mortality events that represent acute welfare harm at enormous scale — and the responses to disease outbreaks carry their own welfare implications.

Key Facts

White Spot Syndrome Virus (WSSV) is the most devastating shrimp disease globally, causing mortality rates of 100% within 3-10 days in affected ponds; annual losses exceed $1 billion
WSSV affects all decapod crustaceans including shrimp, crabs, and crayfish; it is spread through infected seed stock, wild carriers, and contaminated water
Shrimp disease events cause suffering through the progressive physiological deterioration of the virus — affected shrimp stop feeding, show abnormal swimming behaviour, and die
Mass culling of affected shrimp ponds (using chemicals or physical removal) is the standard biosecurity response to WSSV outbreaks — the welfare of culled shrimp depends on the method used
Specific Pathogen Free (SPF) broodstock programmes have significantly reduced disease entry into farmed populations in some regions
Early mortality syndrome (EMS/AHPND), caused by Vibrio parahaemolyticus, causes acute hepatopancreatic necrosis in shrimp — another major welfare and production crisis
Probiotics, biosecurity measures, and improved pond management reduce disease prevalence and welfare harm, but many farms — particularly small-scale operations in Asia — lack access to these tools

Welfare Considerations

Shrimp disease events represent welfare harms at enormous scale: billions of individuals dying of viral or bacterial infections, with the associated physiological distress of disease progression. Under the precautionary principle on decapod sentience, these deaths are not ethically neutral — they represent potential suffering at a scale that demands attention. Mass culling responses — often using formalin, quicklime, or chlorine — may be no more humane than disease death itself if shrimp can experience pain. Biosecurity and disease prevention, which reduce the need for culling events, are therefore welfare-positive as well as economically beneficial. The convergence of welfare and production interests in disease prevention is one of the strongest arguments for industry investment in better biosecurity practices in shrimp farming.

What You Can Do

Choose shrimp from ASC-certified farms, which require disease management plans and biosecurity protocols as part of certification
Support the Shrimp Welfare Project's work on disease management practices that minimise welfare harm in shrimp aquaculture
Reduce shrimp consumption from uncertified sources — commodity shrimp production in many regions operates without meaningful disease welfare oversight
Support research into humane culling methods for shrimp disease response — developing faster, potentially less painful alternatives to current chemical culling methods
Advocate for disease-related welfare provisions in shrimp aquaculture regulations, particularly in major producing countries in Asia